Skip to main content
Top
Published in: BMC Medical Informatics and Decision Making 1/2014

Open Access 01-12-2014 | Research article

A novel method for studying the temporal relationship between type 2 diabetes mellitus and cancer using the electronic medical record

Authors: Adedayo A Onitilo, Rachel V Stankowski, Richard L Berg, Jessica M Engel, Gail M Williams, Suhail A Doi

Published in: BMC Medical Informatics and Decision Making | Issue 1/2014

Login to get access

Abstract

Background

We developed an algorithm for the identification of patients with type 2 diabetes and ascertainment of the date of diabetes onset for examination of the temporal relationship between diabetes and cancer using data in the electronic medical record (EMR).

Methods

The Marshfield Clinic EMR was searched for patients who developed type 2 diabetes between January 1, 1995 and December 31, 2009 using a combination of diagnostic codes and laboratory data. Subjects without diabetes were also identified and matched to subjects with diabetes by age, gender, smoking history, residence, and date of diabetes onset/reference date.

Results

The final cohort consisted of 11,236 subjects with and 54,365 subjects without diabetes. Stringent requirements for laboratory values resulted in a decrease in the number of potential subjects by nearly 70%. Mean observation time in the EMR was similar for both groups with 13—14 years before and 5–7 years after the reference date. The two cohorts were largely similar except that BMI and frequency of healthcare encounters were greater in subjects with diabetes.

Conclusion

The cohort described here will be useful for the examination of the temporal relationship between diabetes and cancer and is unique in that it allows for determination of the date of diabetes onset with reasonable accuracy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, Lin C, Leach C, Cannady RS, Cho H, Scoppa S, Hachey M, Kirch R, Jemal A, Ward E: Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012, 62 (4): 220-241. 10.3322/caac.21149.CrossRefPubMed Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, Lin C, Leach C, Cannady RS, Cho H, Scoppa S, Hachey M, Kirch R, Jemal A, Ward E: Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012, 62 (4): 220-241. 10.3322/caac.21149.CrossRefPubMed
2.
go back to reference American Cancer Society: Cancer Facts and Figures 2012. 2012, Atlanta (GA): American Cancer Society American Cancer Society: Cancer Facts and Figures 2012. 2012, Atlanta (GA): American Cancer Society
4.
go back to reference Stava CJ, Beck ML, Feng L, Lopez A, Busaidy N, Vassilopoulou-Sellin R: Diabetes mellitus among cancer survivors. J Cancer Surviv. 2007, 1 (2): 108-115. 10.1007/s11764-007-0016-z.CrossRefPubMed Stava CJ, Beck ML, Feng L, Lopez A, Busaidy N, Vassilopoulou-Sellin R: Diabetes mellitus among cancer survivors. J Cancer Surviv. 2007, 1 (2): 108-115. 10.1007/s11764-007-0016-z.CrossRefPubMed
5.
go back to reference Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R: Diabetes and cancer. Endocr Relat Cancer. 2009, 16 (4): 1103-1123. 10.1677/ERC-09-0087.CrossRefPubMed Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R: Diabetes and cancer. Endocr Relat Cancer. 2009, 16 (4): 1103-1123. 10.1677/ERC-09-0087.CrossRefPubMed
6.
go back to reference Ko CY, Maggard M, Livingston EH: Evaluating health utility in patients with melanoma, breast cancer, colon cancer, and lung cancer: a nationwide, population-based assessment. J Surg Res. 2003, 114 (1): 1-5. 10.1016/S0022-4804(03)00167-7.CrossRefPubMed Ko CY, Maggard M, Livingston EH: Evaluating health utility in patients with melanoma, breast cancer, colon cancer, and lung cancer: a nationwide, population-based assessment. J Surg Res. 2003, 114 (1): 1-5. 10.1016/S0022-4804(03)00167-7.CrossRefPubMed
7.
go back to reference Thong MS, van de Poll-Franse L, Hoffman RM, Albertsen PC, Hamilton AS, Stanford JL, Penson DF: Diabetes mellitus and health-related quality of life in prostate cancer: 5-year results from the Prostate Cancer Outcomes Study. BJU Int. 2011, 107 (8): 1223-1231. 10.1111/j.1464-410X.2010.09861.x.CrossRefPubMed Thong MS, van de Poll-Franse L, Hoffman RM, Albertsen PC, Hamilton AS, Stanford JL, Penson DF: Diabetes mellitus and health-related quality of life in prostate cancer: 5-year results from the Prostate Cancer Outcomes Study. BJU Int. 2011, 107 (8): 1223-1231. 10.1111/j.1464-410X.2010.09861.x.CrossRefPubMed
8.
go back to reference Edgington A, Morgan MA: Looking beyond recurrence: comorbitidies in cancer survivors. Clin J Oncol Nurs. 2011, 15 (1): E3-E12. 10.1188/11.CJON.E3-E12.CrossRefPubMed Edgington A, Morgan MA: Looking beyond recurrence: comorbitidies in cancer survivors. Clin J Oncol Nurs. 2011, 15 (1): E3-E12. 10.1188/11.CJON.E3-E12.CrossRefPubMed
9.
go back to reference Khan NF, Mant D, Carpenter L, Forman D, Rose PW: Long-term health outcomes in a British cohort of breast, colorectal and prostate cancer survivors: a database study. Br J Cancer. 2011, 105 (Suppl 1): S29-S37.CrossRefPubMedPubMedCentral Khan NF, Mant D, Carpenter L, Forman D, Rose PW: Long-term health outcomes in a British cohort of breast, colorectal and prostate cancer survivors: a database study. Br J Cancer. 2011, 105 (Suppl 1): S29-S37.CrossRefPubMedPubMedCentral
10.
go back to reference Onitilo AA, Engel JM, Glurich I, Stankowski RV, Williams GM, Doi SA: Diabetes and cancer I: risk, survival, and implications for screening. Cancer Causes Control. 2012, 23 (6): 967-981. 10.1007/s10552-012-9972-3.CrossRefPubMedPubMedCentral Onitilo AA, Engel JM, Glurich I, Stankowski RV, Williams GM, Doi SA: Diabetes and cancer I: risk, survival, and implications for screening. Cancer Causes Control. 2012, 23 (6): 967-981. 10.1007/s10552-012-9972-3.CrossRefPubMedPubMedCentral
11.
go back to reference Ferguson RS, Gallagher EJ, Scheinman EJ, Damouni RR, LeRoith D: The epidemiology and molecular mechanisms linking obesity, diabetes, and cancer. Vitam Horm. 2013, 93: 51-98.CrossRefPubMed Ferguson RS, Gallagher EJ, Scheinman EJ, Damouni RR, LeRoith D: The epidemiology and molecular mechanisms linking obesity, diabetes, and cancer. Vitam Horm. 2013, 93: 51-98.CrossRefPubMed
12.
13.
go back to reference Onitilo AA, Engel JM, Glurich I, Stankowski RV, Williams GM, Doi SA: Diabetes and cancer II: role of diabetes medications and influence of shared risk factors. Cancer Causes Control. 2012, 23 (7): 991-1008. 10.1007/s10552-012-9971-4.CrossRefPubMedPubMedCentral Onitilo AA, Engel JM, Glurich I, Stankowski RV, Williams GM, Doi SA: Diabetes and cancer II: role of diabetes medications and influence of shared risk factors. Cancer Causes Control. 2012, 23 (7): 991-1008. 10.1007/s10552-012-9971-4.CrossRefPubMedPubMedCentral
14.
go back to reference Johnson JA, Bowker SL: Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials. Diabetologia. 2011, 54 (1): 25-31. 10.1007/s00125-010-1933-3.CrossRefPubMed Johnson JA, Bowker SL: Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials. Diabetologia. 2011, 54 (1): 25-31. 10.1007/s00125-010-1933-3.CrossRefPubMed
15.
go back to reference Balkau B, Kahn HS, Courbon D, Eschwège E, Ducimetière P, Paris Prospective Study: Hyperinsulinemia predicts fatal liver cancer but is inversely associated with fata cancer at some other sites: the Paris Prospective Study. Diabetes Care. 2001, 24 (5): 843-849. 10.2337/diacare.24.5.843.CrossRefPubMed Balkau B, Kahn HS, Courbon D, Eschwège E, Ducimetière P, Paris Prospective Study: Hyperinsulinemia predicts fatal liver cancer but is inversely associated with fata cancer at some other sites: the Paris Prospective Study. Diabetes Care. 2001, 24 (5): 843-849. 10.2337/diacare.24.5.843.CrossRefPubMed
16.
go back to reference Ahern TP, Hankinson SE, Willet WC, Pollak MN, Eliassen AH, Tamimi RM: Plasma C-peptide, mammographic breast density, and risk of invasive breats cancer. Cancer Epidemiol Biomarkers Prev. 2013, 22 (10): 1786-1796. 10.1158/1055-9965.EPI-13-0375.CrossRefPubMed Ahern TP, Hankinson SE, Willet WC, Pollak MN, Eliassen AH, Tamimi RM: Plasma C-peptide, mammographic breast density, and risk of invasive breats cancer. Cancer Epidemiol Biomarkers Prev. 2013, 22 (10): 1786-1796. 10.1158/1055-9965.EPI-13-0375.CrossRefPubMed
17.
go back to reference Wolpin BM, Bao Y, Qian ZR, Wu C, Kraft P, Ogino S, Stampfer MJ, Sato K, Ma J, Buring JE, Sesso HD, Lee IM, Gaziano JM, McTiernan A, Phillips LS, Chochrane BB, Pollak MN, Manson JE, Giovannucci EL, Fuchs CS: Hyperglycemia, insulin resistance, impaired pancreated β-cell function, and risk of pancreatic cancer. J Natl Cancer Inst. 2013, 105 (14): 1027-1035. 10.1093/jnci/djt123.CrossRefPubMedPubMedCentral Wolpin BM, Bao Y, Qian ZR, Wu C, Kraft P, Ogino S, Stampfer MJ, Sato K, Ma J, Buring JE, Sesso HD, Lee IM, Gaziano JM, McTiernan A, Phillips LS, Chochrane BB, Pollak MN, Manson JE, Giovannucci EL, Fuchs CS: Hyperglycemia, insulin resistance, impaired pancreated β-cell function, and risk of pancreatic cancer. J Natl Cancer Inst. 2013, 105 (14): 1027-1035. 10.1093/jnci/djt123.CrossRefPubMedPubMedCentral
18.
go back to reference Eliassen AH, Tworoger SS, Mantzoros CS, Pollak MN, Hankinson SE: Circulating insulin and c-peptide levels and risk of breast cancer among predominantly premenopausal women. Cancer Epidemiol Biomarkers Prev. 2007, 16 (1): 161-164. 10.1158/1055-9965.EPI-06-0693.CrossRefPubMed Eliassen AH, Tworoger SS, Mantzoros CS, Pollak MN, Hankinson SE: Circulating insulin and c-peptide levels and risk of breast cancer among predominantly premenopausal women. Cancer Epidemiol Biomarkers Prev. 2007, 16 (1): 161-164. 10.1158/1055-9965.EPI-06-0693.CrossRefPubMed
19.
go back to reference Wilke RA, Berg RL, Peissig P, Kitchner T, Sijercic B, McCarty CA, McCarty DJ: Use of an electronic medical record for the identification of research subjects with diabetes mellitus. Clin Med Res. 2007, 5 (1): 1-7. 10.3121/cmr.2007.726.CrossRefPubMedPubMedCentral Wilke RA, Berg RL, Peissig P, Kitchner T, Sijercic B, McCarty CA, McCarty DJ: Use of an electronic medical record for the identification of research subjects with diabetes mellitus. Clin Med Res. 2007, 5 (1): 1-7. 10.3121/cmr.2007.726.CrossRefPubMedPubMedCentral
20.
21.
go back to reference DeStefano F, Eaker ED, Broste SK, Nordstrom DL, Peissig PL, Vierkant RA, Konitzer KA, Gruber RL, Layde PM: Epidemiologic research in an integrated regional medical care system: the Marshfield Epidemiologic Study Area. J Clin Epidemiol. 1996, 49 (6): 643-652. 10.1016/0895-4356(96)00008-X.CrossRefPubMed DeStefano F, Eaker ED, Broste SK, Nordstrom DL, Peissig PL, Vierkant RA, Konitzer KA, Gruber RL, Layde PM: Epidemiologic research in an integrated regional medical care system: the Marshfield Epidemiologic Study Area. J Clin Epidemiol. 1996, 49 (6): 643-652. 10.1016/0895-4356(96)00008-X.CrossRefPubMed
22.
go back to reference Bertram MY, Vos T: Quantifying the duration of pre-diabetes. Aust N Z J Public Health. 2010, 34 (3): 311-314. 10.1111/j.1753-6405.2010.00532.x.CrossRefPubMed Bertram MY, Vos T: Quantifying the duration of pre-diabetes. Aust N Z J Public Health. 2010, 34 (3): 311-314. 10.1111/j.1753-6405.2010.00532.x.CrossRefPubMed
23.
go back to reference Hebert PL, Geiss LS, Tierney EF, Engelgau MM, Yawn BP, McBean AM: Identifying persons with diabetes using Medicare claims data. Am J Med Qual. 1999, 14 (6): 270-277. 10.1177/106286069901400607.CrossRefPubMed Hebert PL, Geiss LS, Tierney EF, Engelgau MM, Yawn BP, McBean AM: Identifying persons with diabetes using Medicare claims data. Am J Med Qual. 1999, 14 (6): 270-277. 10.1177/106286069901400607.CrossRefPubMed
24.
go back to reference Hux JE, Ivis F, Flintoft V, Bica A: Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care. 2002, 25 (3): 512-516. 10.2337/diacare.25.3.512.CrossRefPubMed Hux JE, Ivis F, Flintoft V, Bica A: Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care. 2002, 25 (3): 512-516. 10.2337/diacare.25.3.512.CrossRefPubMed
25.
go back to reference Kudyakov R, Bowen J, Ewen E, West SL, Daoud Y, Fleming N, Masica A: Electronic health record use to classify patients with newly diagnosed versus preexisting type 2 diabetes: infrastructure for comparative effectiveness research and population health management. Popul Health Manag. 2012, 15 (1): 3-11. 10.1089/pop.2010.0084.CrossRefPubMed Kudyakov R, Bowen J, Ewen E, West SL, Daoud Y, Fleming N, Masica A: Electronic health record use to classify patients with newly diagnosed versus preexisting type 2 diabetes: infrastructure for comparative effectiveness research and population health management. Popul Health Manag. 2012, 15 (1): 3-11. 10.1089/pop.2010.0084.CrossRefPubMed
26.
go back to reference Greiver M, Keshavjee K, Martin K, Aliarzadeh B: Who are your patients with diabetes?: EMR case definitions in the Canadian primary care setting. Can Fam Physician. 2012, 58 (7): 804-e421–422PubMedPubMedCentral Greiver M, Keshavjee K, Martin K, Aliarzadeh B: Who are your patients with diabetes?: EMR case definitions in the Canadian primary care setting. Can Fam Physician. 2012, 58 (7): 804-e421–422PubMedPubMedCentral
27.
go back to reference Kandula S, Zeng-Treitler Q, Chen L, Salomon WL, Bray BE: A bootstrapping algorithm to improve cohort identification using structure data. J Biomed Inform. 2011, 44 (Suppl 1): S63-S68.CrossRefPubMed Kandula S, Zeng-Treitler Q, Chen L, Salomon WL, Bray BE: A bootstrapping algorithm to improve cohort identification using structure data. J Biomed Inform. 2011, 44 (Suppl 1): S63-S68.CrossRefPubMed
28.
go back to reference Klompas M, Eggleston E, McVetta J, Lazarus R, Li L, Platt R: Automated detection and classification of type 1 versus type 2 diabetes using electronic health record data. Diabetes Care. 2013, 36 (4): 914-921. 10.2337/dc12-0964.CrossRefPubMedPubMedCentral Klompas M, Eggleston E, McVetta J, Lazarus R, Li L, Platt R: Automated detection and classification of type 1 versus type 2 diabetes using electronic health record data. Diabetes Care. 2013, 36 (4): 914-921. 10.2337/dc12-0964.CrossRefPubMedPubMedCentral
29.
go back to reference Pacheco JA, Thompson W, Kho A: Automatically detecting problem list omissions of type 2 diabetes cases using electronic medical records. AMIA Annu Symp Proc. 2011, 2011: 1062-1069.PubMedPubMedCentral Pacheco JA, Thompson W, Kho A: Automatically detecting problem list omissions of type 2 diabetes cases using electronic medical records. AMIA Annu Symp Proc. 2011, 2011: 1062-1069.PubMedPubMedCentral
30.
go back to reference Km N, Peissig PL, Kho AN, Bielinski SJ, Berg RL, Choudhary V, Basford M, Chute CG, Kullo IJ, Li R, Pacheco JA, Rasmussen LV, Spangler L, Denny JC: Validation of electronic medical record-based phenotyping algorithms: results and lessons learned from the eMERGE network. J Am Med Inform Assoc. 2013, 20 (e1): e147-e154. 10.1136/amiajnl-2012-000896.CrossRef Km N, Peissig PL, Kho AN, Bielinski SJ, Berg RL, Choudhary V, Basford M, Chute CG, Kullo IJ, Li R, Pacheco JA, Rasmussen LV, Spangler L, Denny JC: Validation of electronic medical record-based phenotyping algorithms: results and lessons learned from the eMERGE network. J Am Med Inform Assoc. 2013, 20 (e1): e147-e154. 10.1136/amiajnl-2012-000896.CrossRef
31.
go back to reference Greiver M, Aliarzadeh B, Moineddin R, Meaney C, Ivers N: Diabetes screening with hemoglobin A1c prior to a change in guidelines recommendations: prevalence and patient characteristics. BMC Fam Pract. 2011, 12: 91-10.1186/1471-2296-12-91.CrossRefPubMedPubMedCentral Greiver M, Aliarzadeh B, Moineddin R, Meaney C, Ivers N: Diabetes screening with hemoglobin A1c prior to a change in guidelines recommendations: prevalence and patient characteristics. BMC Fam Pract. 2011, 12: 91-10.1186/1471-2296-12-91.CrossRefPubMedPubMedCentral
32.
go back to reference Suissa S, Azoulay L: Metformin and the risk of cancer: time-related biases in observational studies. Diabetes Care. 2012, 35 (12): 2665-2673. 10.2337/dc12-0788.CrossRefPubMedPubMedCentral Suissa S, Azoulay L: Metformin and the risk of cancer: time-related biases in observational studies. Diabetes Care. 2012, 35 (12): 2665-2673. 10.2337/dc12-0788.CrossRefPubMedPubMedCentral
33.
go back to reference Murdoch TB, Detsky AS: The inevitable application of big data to health care. JAMA. 2013, 309 (13): 1351-1352. 10.1001/jama.2013.393.CrossRefPubMed Murdoch TB, Detsky AS: The inevitable application of big data to health care. JAMA. 2013, 309 (13): 1351-1352. 10.1001/jama.2013.393.CrossRefPubMed
34.
go back to reference Onitilo AA, Stankowski RV, Berg RL, Engel JM, Glurich I, Williams GM, Doi SA: Breast cancer incidence before and after diagnosis of type 2 diabetes mellitus in women: increased risk in the prediabetes phase. Eur J Cancer Prev. 2013, 23 (2): 76-83.CrossRef Onitilo AA, Stankowski RV, Berg RL, Engel JM, Glurich I, Williams GM, Doi SA: Breast cancer incidence before and after diagnosis of type 2 diabetes mellitus in women: increased risk in the prediabetes phase. Eur J Cancer Prev. 2013, 23 (2): 76-83.CrossRef
35.
go back to reference Onitilo AA, Berg RL, Engel JM, Stankowski RV, Glurich I, Williams GM, Doi SA: Prostate cancer risk in pre-diabetic men: a matched cohort study. Clin Med Res. 2013, 11 (4): 201-9. 10.3121/cmr.2013.1160.CrossRefPubMedPubMedCentral Onitilo AA, Berg RL, Engel JM, Stankowski RV, Glurich I, Williams GM, Doi SA: Prostate cancer risk in pre-diabetic men: a matched cohort study. Clin Med Res. 2013, 11 (4): 201-9. 10.3121/cmr.2013.1160.CrossRefPubMedPubMedCentral
36.
go back to reference Onitilo AA, Berg RL, Engel JM, Glurich I, Stankowski RV, Williams G, Doi SA: Increased risk of colon cancer in men in the pre-diabetes phase. PLoS One. 2013, 8 (8): e70426-10.1371/journal.pone.0070426.CrossRefPubMedPubMedCentral Onitilo AA, Berg RL, Engel JM, Glurich I, Stankowski RV, Williams G, Doi SA: Increased risk of colon cancer in men in the pre-diabetes phase. PLoS One. 2013, 8 (8): e70426-10.1371/journal.pone.0070426.CrossRefPubMedPubMedCentral
37.
go back to reference Onitilo AA, Stankowski RV, Berg RL, Engel JM, Glurich I, Williams GM, Doi SA: Type 2 diabetes mellitus, glycemic control, and cancer risk. Eur J Cancer Prev. 2013, 23 (2): 134-140.CrossRef Onitilo AA, Stankowski RV, Berg RL, Engel JM, Glurich I, Williams GM, Doi SA: Type 2 diabetes mellitus, glycemic control, and cancer risk. Eur J Cancer Prev. 2013, 23 (2): 134-140.CrossRef
Metadata
Title
A novel method for studying the temporal relationship between type 2 diabetes mellitus and cancer using the electronic medical record
Authors
Adedayo A Onitilo
Rachel V Stankowski
Richard L Berg
Jessica M Engel
Gail M Williams
Suhail A Doi
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Medical Informatics and Decision Making / Issue 1/2014
Electronic ISSN: 1472-6947
DOI
https://doi.org/10.1186/1472-6947-14-38

Other articles of this Issue 1/2014

BMC Medical Informatics and Decision Making 1/2014 Go to the issue